Studies in rats with BoDV-1 encephalitis showed clinical improvement and reduction in CD4 and CD8 infiltration of the brain after intrathecal administration of the compound, although the virus concentration did not decrease [23]. The gene discussed is CD4; the disease is encephalitis.